Quent Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$82.8K Buy
305
+27
+10% +$6.28K 0.01% 693
2026
Q2
$66K Sell
278
-15
-5% -$3.12K ﹤0.01% 723
2026
Q1
$61.8K Buy
293
+47
+19% +$10.1K ﹤0.01% 673
2025
Q4
$50.6K Buy
246
+26
+12% +$4.89K ﹤0.01% 748
2025
Q3
$34.5K Buy
+220
New +$34K ﹤0.01% 707
2025
Q2
– Sell
-214
Closed -$29.5K – 425
2025
Q1
$29.5K Hold
214
– – ﹤0.01% 673
2024
Q4
$25.3K Sell
214
-17
-7% -$1.98K ﹤0.01% 749
2024
Q3
$25.5K Sell
231
-21
-8% -$2.2K ﹤0.01% 832
2024
Q2
$24.8K Buy
252
+1
+0.4% +$102 ﹤0.01% 797
2024
Q1
$28.1K Buy
251
+92
+58% +$9.9K ﹤0.01% 790
2023
Q4
$16K Buy
159
+1
+0.6% +$99 ﹤0.01% 885
2023
Q3
$13.8K Hold
158
– – ﹤0.01% 865
2023
Q2
$14.9K Buy
158
+1
+0.6% +$84 ﹤0.01% 842
2023
Q1
$11.9K Buy
157
+1
+0.6% +$75 ﹤0.01% 887
2022
Q4
$12.1K Buy
156
+27
+21% +$2.05K ﹤0.01% 859
2022
Q3
$9K Buy
129
+1
+0.8% +$63 ﹤0.01% 872
2022
Q2
$7K Buy
128
+1
+0.8% +$57 ﹤0.01% 891
2022
Q1
$7K Buy
127
+37
+41% +$1.98K ﹤0.01% 970
2021
Q4
$5K Buy
+90
New +$4.41K ﹤0.01% 911

Other funds holding CAH

Quent Capital's CAH Position: Q3 2026 in Review

Quent Capital increased its Cardinal Health (CAH) stake by 9.7% in Q3 2026, buying an estimated $6.28K and bringing the position to 305 shares worth $82.8K. The position accounts for 0.01% of the portfolio, ranked #693.

Quent Capital first reported a position in CAH in Q4 2021 and has held it in 19 quarters since. 952 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Quent Capital held 305 shares of Cardinal Health worth $82.8K as of Q3 2026.
  • Quent Capital bought 27 Cardinal Health shares in Q3 2026, an estimated $6.28K.
  • Cardinal Health made up 0.01% of Quent Capital's portfolio in Q3 2026, its #693 holding.
  • Quent Capital first reported a position in Cardinal Health in Q4 2021 and has held it in 19 quarters since.
  • 952 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.